BioLife Solutions, Inc. vs Neogen
BioLife Solutions, Inc. (BLFS) and Neogen (NEOG) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $1.89B
- Last close
- $38.61
- 12 months
- +45.2%
- Market value
- $2.3B
- Last close
- $10.55
- 12 months
- +95.0%
At a glance
- The biggest part of Neogen's revenue is Food Safety, 74% of the total in its last annual report.
- BioLife Solutions, Inc. and Neogen are close in size by market value ($1.9B and $2.3B).
- Over the last 12 months BioLife Solutions, Inc.'s share price moved +45.2% and Neogen's +95.0%; against the S&P 500 that is +29.4 points and +89.3 points.
- In their last fiscal years BioLife Solutions, Inc. kept -4.8% of revenue as net income and Neogen -0.9%.
- In the last 90 days insiders reported 0 open-market purchases at BioLife Solutions, Inc. and 0 at Neogen; members of Congress disclosed 0 trades in BioLife Solutions, Inc. and 0 in Neogen.
- Next results: BioLife Solutions, Inc. not announced, Neogen Jan 6, 2027.
How each one makes money: Neogen revenue
Share prices on one chart
BioLife Solutions, Inc. and Neogen, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| BioLife Solutions, Inc. BLFSNASDAQ · Health Care Supplies | Neogen NEOGNASDAQ · Health Care Supplies | |
|---|---|---|
| Size and profitability | ||
| Market value | $1.89B | $2.3B |
| Revenue, last fiscal year | $96.2M | $870M |
| Net income, last fiscal year | −$4.59M | −$7.9M |
| Net marginNet income as a share of revenue | -4.8% | -0.9% |
| Free cash flow | $10.6M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is BioLife Solutions, Inc. different from Neogen?
BioLife Solutions, Inc. (BLFS) is in Health Care Supplies on NASDAQ, with $96.2M of revenue in its last fiscal year and a net margin of -4.8%. Neogen (NEOG) is in Health Care Supplies on NASDAQ, with $870M of revenue in its last fiscal year and a net margin of -0.9%. The biggest part of Neogen's revenue is Food Safety, 74% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do BioLife Solutions, Inc. and Neogen compare in size?
Neogen has the larger market value: BioLife Solutions, Inc. $1.89B and Neogen $2.3B, at the last close.
Whose share price rose more over the last 12 months, BLFS or NEOG?
Over the last 12 months BioLife Solutions, Inc. moved +45.2% and Neogen +95.0%. Past price moves say nothing about the future.
Which has had more insider buying, BioLife Solutions, Inc. or Neogen?
Since 2006, Neogen insiders reported 96 open-market purchases against 40 for BioLife Solutions, Inc.. These are counts of what was filed, not a view on either stock.
Do members of Congress trade BLFS or NEOG?
In the last 12 months, members of Congress disclosed 0 trades in BioLife Solutions, Inc. (BLFS) and 0 in Neogen (NEOG).
When did insiders last buy BLFS and NEOG?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
BioLife Solutions, Inc. pageNeogen pageRare insider trades this weekAll comparisons
https://oqro.io/compare/blfs-vs-neog

